참고문헌 (62)

1. Lancet Beasley 351 1225 1998 10.1016/S0140-6736(97)07302-9 T.I.S. of Asthma, Worldwide variation in prevalence of symptoms of asthma, allergic rhinoconjunctivitis, and atopic eczema: ISAAC 

   상세보기

2. J. Allergy Clin. Immunol. Odhiambo 124 2009 10.1016/j.jaci.2009.10.009 Global variations in prevalence of eczema symptoms in children from ISAAC phase three 

   상세보기

3. J. Am. Acad. Dermatol. Simpson 74 491 2016 10.1016/j.jaad.2015.10.043 Patient burden of moderate to severe atopic dermatitis (AD): insights from a phase 2b clinical trial of dupilumab in adults 

   상세보기

4. J. Hum. Genet. Wu 60 675 2015 10.1038/jhg.2015.99 The genomic landscape of human immune-mediated diseases 

   상세보기

5. Immunol. Rev. Boguniewicz 242 233 2011 10.1111/j.1600-065X.2011.01027.x Atopic dermatitis: a disease of altered skin barrier and immune dysregulation 

   상세보기

6. Cell. Signal. Mosenden 23 1009 2011 10.1016/j.cellsig.2010.11.018 Cyclic AMP-mediated immune regulation-overview of mechanisms of action in T cells 

   상세보기

7. J. Pharmacol. Exp. Therapeut. Jimenez 299 753 2001 Phosphodiesterase 4 inhibitors prevent cytokine secretion by T lymphocytes by inhibiting nuclear factor-κB and nuclear factor of activated T cells activation 

8. J. Immunol. Wen 185 6413 2010 10.4049/jimmunol.1001829 The role of the transcription factor CREB in immune function 

   상세보기

9. J. Am. Acad. Dermatol. Hanifin 75 2 297 2016 10.1016/j.jaad.2016.04.001 OPA-15406, a novel, topical, nonsteroidal, selective phosphodiesterase-4 (PDE4) inhibitor, in the treatment of adult and adolescent patients with mild to moderate atopic dermatitis (AD): a phase-II randomized, double-blind, placebo-controlled study 

   상세보기

10. Nat. Rev. Drug Discov. Maurice 13 290 2014 10.1038/nrd4228 Advances in targeting cyclic nucleotide phosphodiesterases 

    상세보기

11. Circ. Res. Omori 100 309 2007 10.1161/01.RES.0000256354.95791.f1 Overview of PDEs and their regulation 

    상세보기

12. J. Med. Chem. Kodimuthali 51 5471 2008 10.1021/jm800582j Recent advances on phosphodiesterase 4 inhibitors for the treatment of asthma and chronic obstructive pulmonary disease 

    상세보기

13. Mol. Pharmacol. Wang 56 170 1999 10.1124/mol.56.1.170 Phosphodiesterase 4B2 is the predominant phosphodiesterase species and undergoes differential regulation of gene expression in human monocytes and neutrophils 

    상세보기

14. J. Clin. Invest. Robichaud 110 1045 2002 10.1172/JCI0215506 Deletion of phosphodiesterase 4D in mice shortens α2-adrenoceptor-mediated anesthesia, a behavioral correlate of emesis 

    상세보기

15. Org. Biomol. Chem. Gorja 11 2075 2013 10.1039/c3ob27424a Novel N-indolylmethyl substituted olanzapine derivatives: their design, synthesis and evaluation as PDE4B inhibitors 

    상세보기

16. Bioorg. Med. Chem. Lett Naganuma 19 3174 2009 10.1016/j.bmcl.2009.04.121 Discovery of selective PDE4B inhibitors 

    상세보기

17. Bioorg. Med. Chem. Lett Goto 24 893 2014 10.1016/j.bmcl.2013.12.076 Identification of the 5, 5-dioxo-7, 8-dihydro-6H-thiopyrano [3, 2-d] pyrimidine derivatives as highly selective PDE4B inhibitors 

    상세보기

18. Bioorg. Med. Chem. Kranz 17 5336 2009 10.1016/j.bmc.2009.03.061 Identification of PDE4B over 4D subtype-selective inhibitors revealing an unprecedented binding mode 

    상세보기

19. Dermatol. Ther. Wittmann 3 1 2013 10.1007/s13555-013-0023-0 Phosphodiesterase 4 inhibition in the treatment of psoriasis, psoriatic arthritis and other chronic inflammatory diseases 

    상세보기

20. J. Clin. Gastroenterol. Buchman 33 289 2001 10.1097/00004836-200110000-00006 Side effects of corticosteroid therapy 

    상세보기

21. Sci. Rep. Bordag 5 2015 10.1038/srep15954 Glucocorticoid (dexamethasone)-induced metabolome changes in healthy males suggest prediction of response and side effects 

    상세보기

22. Curr. Med. Chem. Parikh 23 129 2016 10.2174/0929867323666151117121334 Phosphodiesterase 4 (PDE4) inhibitors in the treatment of COPD: promising drug candidates and future directions 

    상세보기

23. Curr. Pharmaceut. Des. Contreras 23 2073 2017 10.2174/1381612823666170214105651 Selective inhibition of phosphodiesterases 4A, B, C and D Isoforms in chronic respiratory diseases: current and future evidences 

    상세보기

24. Mol. Cell Biol. Arp 23 8042 2003 10.1128/MCB.23.22.8042-8057.2003 Regulation of T-cell activation by phosphodiesterase 4B2 requires its dynamic redistribution during immunological synapse formation 

    상세보기

25. J. Immunol. Asirvatham 173 4806 2004 10.4049/jimmunol.173.8.4806 A-kinase anchoring proteins interact with phosphodiesterases in T lymphocyte cell lines 

    상세보기

26. Biochem. J. Small-Howard 388 465 2005 10.1042/BJ20041682 Anti-inflammatory potential of CB1-mediated cAMP elevation in mast cells 

    상세보기

27. Br. J. Pharmacol. Spina 155 308 2008 10.1038/bjp.2008.307 PDE4 inhibitors: current status 

    상세보기

28. PLoS One Konrad 10 2015 10.1371/journal.pone.0121725 The unrecognized effects of phosphodiesterase 4 on epithelial cells in pulmonary inflammation 

    상세보기

29. Am. J. Respir. Crit. Care Med. Calverley 176 154 2007 10.1164/rccm.200610-1563OC Effect of 1-year treatment with roflumilast in severe chronic obstructive pulmonary disease 

    상세보기

30. Br. J. Pharmacol. Rabe 163 53 2011 10.1111/j.1476-5381.2011.01218.x Update on roflumilast, a phosphodiesterase 4 inhibitor for the treatment of chronic obstructive pulmonary disease 

    상세보기

31. Curr. Opin. Neurobiol. Gray 8 330 1998 10.1016/S0959-4388(98)80057-3 Regulation of ion channels by cAMP-dependent protein kinase and A-kinase anchoring proteins 

    상세보기

32. J. Cell. Physiol. Carvajal 184 409 2000 10.1002/1097-4652(200009)184:3<409::AID-JCP16>3.0.CO;2-K Molecular mechanism of cGMP-mediated smooth muscle relaxation 

    상세보기

33. Expet Rev. Mol. Med. Carroll 15 2013 Differentiation of mesenchymal stem cells to osteoblasts and chondrocytes: a focus on adenosine receptors 

34. Proc. Natl. Acad. Sci. U.S.A. Khan 113 746 2016 10.1073/pnas.1524272113 Sympathetic innervation controls homeostasis of neuromuscular junctions in health and disease 

    상세보기

35. Nat. Rev. Mol. Cell Biol. Wang 16 678 2015 10.1038/nrm4074 Transcriptional regulation of hepatic lipogenesis 

    상세보기

36. Cell Death Dis. Wang 7 2016 10.1038/cddis.2016.106 A cardiac mitochondrial cAMP signaling pathway regulates calcium accumulation, permeability transition and cell death 

    상세보기

37. J. Am. Acad. Dermatol. Bissonnette 75 99 2016 10.1016/j.jaad.2016.02.1164 

    상세보기

38. J. Med. Chem. Felding 57 5893 2014 10.1021/jm500378a Discovery and early clinical development of 2-{6-[2-(3, 5-dichloro-4-pyridyl) acetyl]-2, 3-dimethoxyphenoxy}-N-propylacetamide (LEO 29102), a soft-drug inhibitor of phosphodiesterase 4 for topical treatment of atopic dermatitis 

    상세보기

39. Eur. J. Med. Chem. Cherukupalli 126 298 2017 10.1016/j.ejmech.2016.11.019 An insight on synthetic and medicinal aspects of pyrazolo [1, 5-a] pyrimidine scaffold 

    상세보기

40. Eur. J. Med. Chem. Taltavull 46 4946 2011 10.1016/j.ejmech.2011.07.054 Synthesis and biological activity of pyrido [3′, 2′: 4, 5] furo [3, 2-d] pyrimidine derivatives as novel and potent phosphodiesterase type 4 inhibitors 

    상세보기

41. Mol. Inform D'Ursi 35 369 2016 10.1002/minf.201501033 Further insights in the binding mode of selective inhibitors to human PDE4D enzyme combining docking and molecular dynamics 

    상세보기

42. Bioorg. Med. Chem. Lett Donnell 20 2163 2010 10.1016/j.bmcl.2010.02.044 Identification of pyridazino [4, 5-b] indolizines as selective PDE4B inhibitors 

    상세보기

43. J. Med. Chem. Gillis 58 8315 2015 10.1021/acs.jmedchem.5b00258 Applications of fluorine in medicinal chemistry 

    상세보기

44. J. Med. Chem. Hagmann 51 4359 2008 10.1021/jm800219f The many roles for fluorine in medicinal chemistry 

    상세보기

45. J. Am. Chem. Soc. Littke 122 4020 2000 10.1021/ja0002058 Versatile catalysts for the Suzuki cross-coupling of arylboronic acids with aryl and vinyl halides and triflates under mild conditions 

    상세보기

46. B. Gopalan, L.A. Gharat, B. Chandrasekhar, B.G. Pillai, Process for the preparation of n-(3, 5-dichloropyrid-4-yl)-4-difluoromethoxy-8-methanesulfonamido-dibenzo [b, d] furan-1-carboxamide, in, Google Patents, 2009. 

47. Mol. Pharmacol. Dym 61 20 2002 10.1124/mol.61.1.20 Molecular docking of competitive phosphodiesterase inhibitors 

    상세보기

48. Science Xu 288 1822 2000 10.1126/science.288.5472.1822 Atomic structure of PDE4: insights into phosphodiesterase mechanism and specificity 

    상세보기

49. Mol. Divers. Guariento 20 77 2016 10.1007/s11030-015-9631-1 New insights into PDE4B inhibitor selectivity: CoMFA analyses and molecular docking studies 

    상세보기

50. Structure Card 12 2233 2004 10.1016/j.str.2004.10.004 Structural basis for the activity of drugs that inhibit phosphodiesterases 

    상세보기

51. Smart 57 1994 Organofluorine Chemistry Characteristics of CF systems 

52. ChemMedChem Morgenthaler 2 1100 2007 10.1002/cmdc.200700059 Predicting and tuning physicochemical properties in lead optimization: amine basicities 

    상세보기

53. J. Med. Chem. Bissantz 53 5061 2010 10.1021/jm100112j A medicinal chemist's guide to molecular interactions 

    상세보기

54. Mini Rev. Med. Chem. Zhou 10 309 2010 10.2174/138955710791331016 Rediscovery of halogen bonds in protein-ligand complexes 

    상세보기

55. J. Recept. Signal. Transduct Perozzo 24 1 2004 10.1081/RRS-120037896 Thermodynamics of protein-ligand interactions: history, presence, and future aspects 

    상세보기

56. J. Allergy Clin. Immunol. Stone 125 S73 2010 10.1016/j.jaci.2009.11.017 IgE, mast cells, basophils, and eosinophils 

    상세보기

57. Crit. Rev. Eukaryot. Gene Expr. Parameswaran 20 2010 10.1615/CritRevEukarGeneExpr.v20.i2.10 Tumor necrosis factor-α signaling in macrophages 

    상세보기

58. Acta Crystallogr. A. Clark 51 887 1995 10.1107/S0108767395007367 The analytical calculation of absorption in multifaceted crystals 

    상세보기

59. J. Appl. Crystallogr. Dolomanov 42 339 2009 10.1107/S0021889808042726 OLEX2: a complete structure solution, refinement and analysis program 

    상세보기

60. Proc. Natl. Acad. Sci. U.S.A. Xia 106 2412 2009 10.1073/pnas.0813020106 Identification of compounds that potentiate CREB signaling as possible enhancers of long-term memory 

    상세보기

61. Biochem. Pharmacol. Pan 48 827 1994 10.1016/0006-2952(94)90062-0 Synergistic interactions between selective pharmacological inhibitors of phosphodiesterase isozyme families PDE III and PDE IV to attenuate proliferation of rat vascular smooth muscle cells 

    상세보기

62. Int. Immunol. Matsuda 9 461 1997 10.1093/intimm/9.3.461 Development of atopic dermatitis-like skin lesion with IgE hyperproduction in NC/Nga mice 

    상세보기